Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
One-Hour Low-Cost Multipurpose Highly Efficient System (HOLMES) Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Diagnostics Market CAGR Outlook And Future Development
The one-hour low-cost multipurpose highly efficient system (holmes) clustered regularly interspaced short palindromic repeats (crispr) diagnostics market has witnessed significant expansion in recent years. It is anticipated to grow from $1.49 billion in 2025 to $1.79 billion in 2026, achieving a compound annual growth rate (CAGR) of 20.1%. The market’s past growth was spurred by several factors, including the expansion in molecular diagnostics, the broadening scope of crispr research, an increase in infectious disease testing, the rising demand for rapid tests, and progress in genomics technology.
The market for the one-hour low-cost multipurpose highly efficient system (HOLMES) clustered regularly interspaced short palindromic repeats (CRISPR) diagnostics is projected to grow significantly in the near future. It is expected to reach a valuation of $3.75 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 20.4%. This growth during the forecast period can be attributed to the expanding scope of point-of-care molecular testing, increasing demand for rapid pathogen detection, advancements in personalized diagnostics, greater clinical adoption of CRISPR, and the availability of broader field-deployable testing options. Major developments anticipated in this period include swift CRISPR-based diagnostic assays, point-of-care CRISPR testing kits, multiplex gene detection panels, portable molecular CRISPR platforms, and cost-effective nucleic acid detection kits.
Get A Free Sample Report With In-Depth Market Insights:
One-Hour Low-Cost Multipurpose Highly Efficient System (HOLMES) Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Diagnostics Market Growth Drivers: What’s Behind The Acceleration?
The growing occurrence of infectious diseases is projected to fuel the expansion of the hybrid oligonucleotide linked modular enzyme system (HOLMES) clustered regularly interspaced short palindromic repeats (CRISPR) diagnostics market. These ailments arise when the body is invaded by detrimental microorganisms, capable of spreading via contact, air, water, or various carriers. The increase in infectious diseases is linked to urbanization and dense populations, which accelerate pathogen transmission. HOLMES CRISPR Diagnostics facilitates the detection of infectious diseases by employing CRISPR-Cas enzymes to swiftly and precisely identify unique genetic sequences of pathogens, thus enabling quick, sensitive, and point-of-care diagnoses. As an illustration, in February 2024, GOV.UK, a government body based in the UK, reported that tuberculosis (TB) cases in England saw a 10.7% rise in 2023, increasing from 4,380 in 2022 to 4,850. Consequently, the escalating incidence of infectious diseases is stimulating the growth of the hybrid oligonucleotide linked modular enzyme system (HOLMES) clustered regularly interspaced short palindromic repeats (CRISPR) diagnostics market.
One-Hour Low-Cost Multipurpose Highly Efficient System (HOLMES) Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Diagnostics Market Segment Landscape And Growth Outlook
The one-hour low-cost multipurpose highly efficient system (holmes) clustered regularly interspaced short palindromic repeats (crispr) diagnostics market covered in this report is segmented –
1) By Product Type: Kits; Instruments; Reagents; Other Product Types
2) By Service Type: Sample Collection And Preparation Services; Assay Development And Validation Services; Data Interpretation And Reporting Services; Quality Control And Assurance Services
3) By Application: Infectious Disease Diagnosis; Oncology; Genetic Disease Screening; Other Applications
4) By End-User: Hospitals And Clinics; Diagnostic Laboratories; Research Institutes; Other End-Users
Subsegments:
1) By Kits: Single Target Diagnostic Kits; Multiplex Diagnostic Kits; Point Of Care Testing Kits; Laboratory Use Diagnostic Kits; Disease Specific Diagnostic Kits
2) By Instruments: Benchtop Diagnostic Instruments; Portable Diagnostic Devices; Automated Detection Systems; Sample Preparation Instruments; Integrated Analysis Platforms
3) By Reagents: Enzyme Based Reagents; Nucleic Acid Extraction Reagents; Amplification Reaction Reagents; Detection And Reporting Reagents; Sample Stabilization Reagents
4) By Other Product Types: Consumables And Accessories; Quality Control Materials; Calibration Standards; Disposable Testing Components; Supporting Laboratory Supplies
One-Hour Low-Cost Multipurpose Highly Efficient System (HOLMES) Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Diagnostics Market Leading Players And Competitive Positioning
Major companies operating in the one-hour low-cost multipurpose highly efficient system (holmes) clustered regularly interspaced short palindromic repeats (crispr) diagnostics market are Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Integrated DNA Technologies Inc., GenScript Biotech Corporation, OraSure Technologies Inc., Molbio Diagnostics Pvt. Ltd., New England Biolabs Inc., Horizon Discovery Group plc, Mammoth Biosciences, Synthego Corporation, Binx Health Inc., Sherlock Biosciences Inc., Caspr Biotech, Tolo Biotechnology Co. Ltd., CrisprBits Private Limited, Scope Biosciences.
View The Full One-Hour Low-Cost Multipurpose Highly Efficient System (HOLMES) Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Diagnostics Market Report:
One-Hour Low-Cost Multipurpose Highly Efficient System (HOLMES) Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Diagnostics Market Regional Split: Which Areas Are Fueling Growth?
North America was the largest region in the hybrid oligonucleotide linked modular enzyme system (HOLMES) clustered regularly interspaced short palindromic repeats (CRISPR) diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the one-hour low-cost multipurpose highly efficient system (holmes) clustered regularly interspaced short palindromic repeats (crispr) diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
